Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

ACROBiosystems Recombinant Protein;Human Integrin alpha V beta 3 (ITGAV&ITGB3) Heterodimer Protein;HEK293;100UG;IT3,Integrin alpha V beta 3,ITGAV&ITGB3,Integrin,ITGAV,ITGA,ITGB3,ITGB,ITGAVB3

Supplier:  ACROBiosystems IT3H52E3100UG


Recombinant Protein;Human Integrin alpha V beta 3 (ITGAV&ITGB3) Heterodimer Protein;100UG;Human ITGAV&ITGB3, His Tag (IT3-H52E3) is expressed from human 293 cells (HEK293). It contains AA Phe 31 - Val 992 (ITGAV) & Gly 27 - Asp 718 (ITGB3) (Accession # NP_002201 (ITGAV) & AAI27667.1 (ITGB3)).;Human ITGAV & ITGB3 Heterodimer Protein, produced by co-expression of ITGAV and ITGB3, has a calculated MW of 113 kDa (ITGAV) and 81.8 kDa (ITGB3). Subunit ITGAV is fused with an acidic tail at the C-terminus and followed by a polyhistidine tag and subunit ITGB3 contains no tag but a basic tail at the C-terminus. The predicted N-terminus is Phe 31 (ITGAV) & Gly 27 (ITGB3). The reducing (R) protein migrates as 145 kDa (ITGAV) and 100-116 kDa (ITGB3) respectively due to glycosylation.;Immobilized Human ITGAVB3, His Tag (Cat. No. IT3-H52E3) at 5 μg/mL (100 μL/well) can bind Biotinylated TGF-Beta 1, N-His with a linear range of 0.2-5 μg/mL (QC tested).;Immobilized Human Fibronectin at 5μg/mL (100μL/we

Catalog No. 50-108-9643

Add to Cart

Provide Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit